A lot of pluses but they seem unable to get their costs under control.
While great growth considering, its operating costs are way too high. And then corporate costs on top of that
- Forums
- ASX - By Stock
- BUB
- Ann: FY21 Q2 Activity Report and Appendix 4C Cashflow Statement
Ann: FY21 Q2 Activity Report and Appendix 4C Cashflow Statement, page-2
-
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.1M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 13.0¢ | $37.80K | 290.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 443563 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 571614 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 443595 | 0.130 |
44 | 1677860 | 0.125 |
55 | 2693388 | 0.120 |
41 | 2227464 | 0.115 |
33 | 775086 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 571614 | 26 |
0.140 | 1678615 | 31 |
0.145 | 1515120 | 26 |
0.150 | 1907309 | 31 |
0.155 | 511671 | 19 |
Last trade - 14.41pm 21/10/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online